XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Revenues [Abstract]    
REVENUES $ 5,837,839 $ 6,304,741
COST OF GOODS SOLD 507,418 806,038
GROSS PROFIT 5,330,421 5,498,703
Operating expenses    
Selling, general and administrative expense 5,735,833 5,275,402
Depreciation / Amortization 83,890 80,648
Bad debt expense 12,558 22,207
Total operating expenses 5,832,281 5,378,257
Operating income/(loss) (501,860) 120,444
Other income / (expense)    
Income from equity method investment - Cellerate, LLC 9,951 0
Gain on settlement of debt 0 286,873
Debt forgiveness 0 50,646
Change in fair value of Derivative Liability 0 44
Other income (22,078) 125
Interest Expense (86,587) (126,825)
Total other income / (expense) (98,714) 210,863
Net income/(loss) (600,574) 331,309
Series C Preferred stock inducement dividends (103,197) 0
Series C Preferred Stock Dividends (28,061) (139,006)
Net income/(loss) available to common stockholders $ (731,832) $ 192,303
Basic loss per share of common stock $ (0.00) $ 0.00
Diluted net loss per share of common stock $ (0.00) $ 0.00
Weighted average number of common shares outstanding, basic 217,163,538 111,381,832
Weighted average number of common shares outstanding, diluted 217,163,538 208,645,538